US OptionsDetailed Quotes
NVO240809P120000
- 0.12
- -2.20-94.83%
15min DelayTrading Aug 8 12:11 ET
0.74High0.12Low
0.20Open2.32Pre Close1.14K Volume1.17K Open Interest120.00Strike Price33.34KTurnover46.24%IV4.32%PremiumAug 9, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type-0.0669Delta0.0350Gamma1044.08Leverage Ratio-0.1067Theta-0.0003Rho-69.80Eff Leverage0.0104Vega
Novo-Nordisk A/S Stock Discussion
Sign in to post a comment
$NVIDIA (NVDA.US)$ niceee jobless claims much lower than estimates!! 🚀🚀 $Alphabet-C (GOOG.US)$ $Taiwan Semiconductor (TSM.US)$ $Eli Lilly and Co (LLY.US)$ $Novo-Nordisk A/S (NVO.US)$
9
1
$Novo-Nordisk A/S (NVO.US)$ shares tumbled 8.4% on Wednesday after the pharmaceutical giant announced disappointing second-quarter results for 2024. The company's flagship drugs, Ozempic and Wegovy, both reported significant sales increases but fell short of analysts' expectations. Ozempic, used for treating type 2 diabetes, saw a 30% rise in sales to $4.26 billion, below the anticipated $4.38 billion. Wegovy, aimed at obesity...
6
1
The dovish stance of the Bank of Japan calmed market sentiment, with $Dow Jones Industrial Average (.DJI.US)$ initially surging by as much as 480 points or 1.2%, $S&P 500 Index (.SPX.US)$up by 1.7% at its peak, $Nasdaq Composite Index (.IXIC.US)$ by 2.1%, $Russell 2000 Index (.RUT.US)$ by 1.5%, the Philadelphia Semiconductor Index by 3.8%, and the Chinese Concept Stocks Index by 1.5%.
However, due to rising Middle East tensions and weak demand for the 10-year US Treasury auction, the market's...
However, due to rising Middle East tensions and weak demand for the 10-year US Treasury auction, the market's...
4
Wednesday began with another rebound trading session, but after noon indexes began to pullback. For the day, the once positive market finished down, and each index continued lowering into correction territory.
Just past the 4 pm close, the $S&P 500 Index (.SPX.US)$ fell , the $Dow Jones Industrial Average (.DJI.US)$ fell 0.60%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 1.05%.
MACRO
The CBOE's Volatility Index (VI...
Just past the 4 pm close, the $S&P 500 Index (.SPX.US)$ fell , the $Dow Jones Industrial Average (.DJI.US)$ fell 0.60%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 1.05%.
MACRO
The CBOE's Volatility Index (VI...
41
5
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Good day, traders. Happy Wednesday, Aug 7th. The market is rebounding thanks to a lighter earnings week, and lower volatility overall. My name is Kevin Travers; here are stories herd on Wall Street: these are today's moovin' stonks.
$Novo-Nordisk A/S (NVO.US)$, the Wegovy and Ozempic seller saw its stock fell 7% after the firm said on Wednesday its profit rose 3% to 20 billion Danish kroner ($2.93 billion), or 4.49 kroner a share...
$Novo-Nordisk A/S (NVO.US)$, the Wegovy and Ozempic seller saw its stock fell 7% after the firm said on Wednesday its profit rose 3% to 20 billion Danish kroner ($2.93 billion), or 4.49 kroner a share...
11
6
Morning Movers
Gapping up
$Shopify (SHOP.US)$ stock soared 17% after the e-commerce platform surpassed quarterly revenue expectations, with its artificial intelligence-powered tools attracting more merchants.
$Disney (DIS.US)$ stock rose by 0.16% in volatile trading as its Entertainment unit, housing Disney+, Hulu, and ESPN+, turning a profit for the first time.
Gapping down
$Super Micro Computer (SMCI.US)$ stock fell 14.2% follo...
Gapping up
$Shopify (SHOP.US)$ stock soared 17% after the e-commerce platform surpassed quarterly revenue expectations, with its artificial intelligence-powered tools attracting more merchants.
$Disney (DIS.US)$ stock rose by 0.16% in volatile trading as its Entertainment unit, housing Disney+, Hulu, and ESPN+, turning a profit for the first time.
Gapping down
$Super Micro Computer (SMCI.US)$ stock fell 14.2% follo...
31
5
$Novo-Nordisk A/S (NVO.US)$ gambateh, it a good share. Phase IIIa FRONTIER 2 trial, which evaluated the efficacy and safety of Mim8 very promising.
$Novo-Nordisk A/S (NVO.US)$ If it dares to get even cheaper after this ER, Mr Market is overly generous![]()
2
No comment yet
Silverbat : Interest stays?